What is LOPJLB’s current signal on IMMP?

LOPJLB’s latest quantitative signal on Immutep Limited (IMMP) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is IMMP in?

Immutep Limited (IMMP) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Immutep Limited based / listed?

Immutep Limited is based in AU, listed on NASDAQ.

Immutep Limited (IMMP)

COMPARE

Healthcare · Biotechnology · NASDAQ · AU

$3.63-5.47%Close

SELLCRISIS · day 20

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $535M
Beta: 2.31
P/E (TTM): -0.58

Short % float: 0.03%
Days to cover: 2.0
SI change: -95.2%

1W: -16.55%
1M: -44.15%

vs SPY 1W: -17.71%
vs SPY 1M: -47.15%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on…

Employees: 53
Headquarters: AU
Founded: 2012
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 147.4M
Float: 97.1%

immutep.com ↗

Key executives

Marc Voigt — Chief Executive Officer, MD, Chief Financial Officer, Chief Business Officer & Executive Director

Frederic Triebel — Chief Scientific Officer & Executive Director

Stephan Winckels — Chief Medical Officer

SEC filings

EDGAR · CIK 15061840 · IMMP

Analyst consensus

Buy

Bullish250.0%

Neutral250.0%

Bearish00.0%

L $3.50Avg $4.25H $5.00

Target$4.25+17.08%

Last$3.63

Key stats

Industry peers

Prediction markets

Company news